You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Litigation Details for Spectrum Pharmaceuticals, Inc. v. Eurohealth International Sarl (D. Nev. 2014)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Spectrum Pharmaceuticals, Inc. v. Eurohealth International Sarl
The small molecule drug covered by the patent cited in this case is ⤷  Try a Trial .

Details for Spectrum Pharmaceuticals, Inc. v. Eurohealth International Sarl (D. Nev. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-06-18 1 the expiration of United States Patent No. 6,500,829 (“the ‘829 patent”), which covers 12 Fusilev®. …Trademark Office issued 18 U.S. Patent No. 6,500,829, entitled “Substantially Pure Diastereoisomers of Tetrahydrofolate… COUNT FOR INFRINGEMENT OF U.S. PATENT NO. 6,500,829 28 20. Plaintiffs reallege … 1. This is an action for patent infringement under the patent laws of the United 6 States, 35… THE PATENT-IN-SUIT 17 10. On December 31, 2002, the United States Patent and Trademark External link to document
2014-11-24 48 expiration of 18 United States Patent No. 6,500,829 (“the ‘829 patent”). Plaintiffs contend that West-Ward…the expiration of United States Patent No. 6,500,829 13 (“the ‘829 patent”), which covers Fusilev®. 14…Trademark Office issued 24 U.S. Patent No. 6,500,829, entitled “Substantially Pure Diastereoisomers of Tetrahydrofolate… COUNT FOR INFRINGEMENT OF U.S. PATENT NO. 6,500,829 16 25. Plaintiffs reallege …would infringe 20 the ‘829 patent and Plaintiffs contend that the ‘829 patent is valid and enforceable. External link to document
2014-11-24 50 3/24/2015. (Attachments: # 1 Exh. A U.S. Patent No. 6,500,829) (Labbe, John) (Entered: 11/24/2014) … AMENDED COMPLAINT for Patent Infringement against Eurohealth International Sarl, West-Ward Pharmaceutical…18 June 2014 2:14-cv-00980-GMN-PAL Patent None District Court, D. Nevada External link to document
2015-06-19 63 current litigation involves the same patent (U.S. Patent 6,500,829) as the 9 related case Spectrum Pharmaceuticals…18 June 2014 2:14-cv-00980-GMN-PAL Patent None District Court, D. Nevada External link to document
2015-06-23 64 alleging infringement of U.S. Patent 3 No. 6,500,829 (the “’829 Patent”) under U.S.C. 271(a), (b), (…18 June 2014 2:14-cv-00980-GMN-PAL Patent None District Court, D. Nevada External link to document
2016-06-09 69 this action alleging infringement of U.S. Patent 3 No. 6,500,829 under U.S.C. §§ 271(a), (b), (c), and …claims 1 and 2 of the ’829 patent are invalid, and 9 claims 3-14 of the ’829 patent are not infringed by ANDA…18 June 2014 2:14-cv-00980-GMN-PAL Patent None District Court, D. Nevada External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.